Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT06111950
Eligibility Criteria:
Inclusion Criteria:
TALS, RFMN, LWS or other pathology patients
* Woman or man
* All ages
* Presence of bi-allelic mutations of RNU4ATAC or RTTN
* Written consent of parents or legal guardian(s)
* Affiliation to a Social Security scheme
Healthy participants (Parent of the patient)
* Woman or man
* Major
* Presence of mono-allelic mutations of RNU4ATAC
* Written consent of the participant
* Affiliation to a Social Security scheme
Parents having recourse to a medical termination of pregnancy or having had a spontaneous miscarriage (for fetus samples)
* Woman or man
* Major
* Presence of bi-allelic mutations of RNU4ATAC or RTTN in the fetus
* Written parental consent
* Affiliation to a Social Security scheme
Exclusion Criteria:
Subject participating in another research including an exclusion period still in progress.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT06111950
Study Brief:
Protocol Section:
NCT06111950